Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs …

Published October 23, 2013

Sideris Pharmaceuticals Completes Million Equity Financing and Signs …
"We believe that SP-420 has the potential to be the best-in-class therapeutic approach for the treatment of transfusion related iron overload," stated Thomas Neenan, PhD, Sideris founder and Chief Technology Officer. The combination of the Novartis … Read more on MarketWatch

TO YOUR HEALTH: Oct. 23
Massachusetts Bay Commuter Railroad's Workforce Diversity Advisory Council will host a “TRAIN-sylvania” blood drive Thursday, Oct. 24, at South Station in Boston to benefit patients of Brigham and Women's Hospital and Dana Farber Cancer Institute. The … Read more on Wicked Local

Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
In lab studies at Novartis Oncology, researchers found that the drug was able to stunt the growth of tumor cells, demonstrating its promise as an add-on combo drug that could prevent resistance to other treatments in the pipeline. … a better program … Read more on FierceBiotech

Substance Abuse Hotline MA (888) 978-4179
Substance Abuse Hotline MA – Looking for Substance Abuse Hotline MA? Call (888) 978-4179 for Substance Abuse Hotline MA. Available 24 hrs a day, 7 days a wee…